FALCO HOLDINGS CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,245 JPY | -0.88% |
|
+0.72% | +7.52% |
| Sales 2024 * | 43B 276M | Sales 2025 * | 43.5B 279M | Capitalization | 24.17B 155M |
|---|---|---|---|---|---|
| Net income 2024 * | 1.65B 10.6M | Net income 2025 * | 1.52B 9.77M | EV / Sales 2024 * | 0.34 x |
| Net cash position 2024 * | 9.6B 61.66M | Net cash position 2025 * | 9.65B 62M | EV / Sales 2025 * | 0.33 x |
| P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
16.1
x | Employees | 1,159 |
| Yield 2024 * |
5.08% | Yield 2025 * |
5.3% | Free-Float | 66.19% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.88% | ||
| 1 week | +0.72% | ||
| Current month | -3.98% | ||
| 1 month | -4.47% | ||
| 3 months | +2.05% | ||
| 6 months | +14.42% | ||
| Current year | +7.52% |
1 week
2 160.00
2 270.00
1 month
2 160.002 367.00
Current year
1 981.002 370.00
1 year
1 770.002 370.00
3 years
1 616.002 370.00
5 years
1 235.002 370.00
10 years
998.002 370.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tadashi Yasuda
PSD | President | 65 | 95-01-31 |
Norikazu Ohnishi
ADM | Chief Administrative Officer | 57 | 17-06-30 |
Tetsuo Goda
BRD | Director/Board Member | 58 | 18-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tadashi Yasuda
PSD | President | 65 | 95-01-31 |
| Director/Board Member | 65 | 89-03-31 | |
Kinya Naito
BRD | Director/Board Member | 68 | 16-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 19 M€ | +2.79% | ||
| 0.00% | 18 M€ | +16.15% | - | |
| 0.00% | 144,586 M€ | +13.76% | ||
| 0.00% | 66,066 M€ | +13.80% | - | |
| 0.00% | 20,721 M€ | +12.65% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2,245 | -0.88% | 7 700 |
| 24-04-24 | 2,265 | +2.12% | 13,200 |
| 24-04-23 | 2,218 | +0.68% | 6,400 |
| 24-04-22 | 2,203 | +1.47% | 7,900 |
| 24-04-19 | 2,171 | -2.60% | 17,600 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
FALCO HOLDINGS Co.,Ltd is a Japan-based company mainly engaged in the clinical testing business and the dispensing pharmacy business. The Company operates in two business segments. The Clinical Testing segment is engaged in the contracted clinical specimen testing business for hospitals and clinics, as well as the development and sale of electronic medical charts and other medical information systems, and the wholesale of in-vitro diagnostic drugs. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies.
Calendar
2024-05-09
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2,265
JPY
Average target price
2,200
JPY
Spread / Average Target
-2.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.52% | 156M | |
| -16.65% | 8.34B | |
| +39.98% | 3.59B | |
| -32.00% | 2.75B | |
| -7.71% | 2.48B | |
| -9.22% | 2.32B | |
| -13.29% | 1.79B | |
| -19.46% | 1.54B | |
| -40.57% | 1.21B | |
| +9.70% | 1.13B |
- Stock Market
- Equities
- 4671 Stock
